AU7470794A - 2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease - Google Patents

2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease

Info

Publication number
AU7470794A
AU7470794A AU74707/94A AU7470794A AU7470794A AU 7470794 A AU7470794 A AU 7470794A AU 74707/94 A AU74707/94 A AU 74707/94A AU 7470794 A AU7470794 A AU 7470794A AU 7470794 A AU7470794 A AU 7470794A
Authority
AU
Australia
Prior art keywords
treatement
deoxyadenosine
halo
inflammatory bowel
bowel disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74707/94A
Inventor
Carlos J. Carrera
Dennis A. Carson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU7470794A publication Critical patent/AU7470794A/en
Priority to AU18593/99A priority Critical patent/AU735319B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU74707/94A 1994-05-26 1994-05-26 2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease Abandoned AU7470794A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU18593/99A AU735319B2 (en) 1994-05-26 1999-03-04 2-halo-2'-deoxyadenosine treatment for inflammatory bowel disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/005971 WO1995032718A1 (en) 1994-05-26 1994-05-26 2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU18593/99A Division AU735319B2 (en) 1994-05-26 1999-03-04 2-halo-2'-deoxyadenosine treatment for inflammatory bowel disease

Publications (1)

Publication Number Publication Date
AU7470794A true AU7470794A (en) 1995-12-21

Family

ID=22242613

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74707/94A Abandoned AU7470794A (en) 1994-05-26 1994-05-26 2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease

Country Status (4)

Country Link
JP (1) JPH10505323A (en)
AU (1) AU7470794A (en)
CA (1) CA2191230C (en)
WO (1) WO1995032718A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7528247B2 (en) 2001-08-02 2009-05-05 Genzyme Corporation Process for preparing purine nucleosides
US7368423B1 (en) * 2001-12-05 2008-05-06 The Scripps Research Institute Composition and method for treating chronic allograft rejection
US20060135463A1 (en) * 2002-09-27 2006-06-22 Wood Christopher B Methods and compositions for the treatment of lupus using clofarabine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310732A (en) * 1986-02-03 1994-05-10 The Scripps Research Institute 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis
KR0138996B1 (en) * 1988-03-16 1998-04-30 레이몬드 에이치. 칸 Substituted adenine derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA2191230C (en) 2001-02-27
JPH10505323A (en) 1998-05-26
WO1995032718A1 (en) 1995-12-07
CA2191230A1 (en) 1995-12-07

Similar Documents

Publication Publication Date Title
GB2317778B (en) Endoscope
AU657899B3 (en) Multipurpose sickbed
EP0713672A3 (en) Endoscope
EP0694307A4 (en) Atopic disease remedy
AU3075895A (en) Endoscope
EP0774916A4 (en) Endoscope
GB9504331D0 (en) Antithrombotic agents
GB2301148A8 (en) Hydraulic fan coupling
AU2725795A (en) Tournament system
AU1975195A (en) Antithrombotic agents
GB9518692D0 (en) 'Spraymate'
AU3234895A (en) 5'-dithio-modified oligonucleotides
GB2294000A8 (en) Thixocasting
HK1002194A1 (en) Carbostyril derivatives as antithrombotic agents
AU7470794A (en) 2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease
AU1884395A (en) Antithrombotic agents
GB9515838D0 (en) Angler's aid
GB2307644B (en) Resectoscope
AU9055091A (en) Treatment for inflammatory bowel disease
ZA951615B (en) Antithrombotic agents
AU7042998A (en) Conduits formes d'un tube metallique gaine
HUP9903369A3 (en) 8(9)-dehydroestradiol derivatives
ZA951955B (en) Multipurpose sickbed
KR0107735Y1 (en) Condoms
SI0801571T1 (en) Soluble 2-chloro-2'-deoxyadenosine formulations